Actavis-Allergan Deal Gets U.S. Antitrust Approval - Quick Facts

(RTTNews) - Actavis Plc. (ACT) and Allergan, Inc. (AGN) said the U.S. Federal Trade Commission has granted early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 with respect to Actavis' pending acquisition of Allergan.

On December 1, 2014, Actavis and Allergan filed Pre-Merger Notification and Report Forms required under the HSR Act with the FTC. On December 29, 2014, Actavis voluntarily withdrew and subsequently re-filed these forms.

The early termination of the waiting period under the HSR Act satisfies one of the conditions to the closing of the pending acquisition.

Actavis and Allergan also said today they have set the close of business on January 22 as the record date for determining the shareholders that will be entitled to vote at their respective special meetings of shareholders to be held in connection with the pending acquisition.